EUVIMEDEUVIMED entdecken
Crossref

P2Y12 receptor-independent antiplatelet mechanism of cryptotanshinone: Network pharmacology and experimental validation of multi-target signaling pathways

Yi Xiao, Rui Zhang, Chaoying Hua, Meng Wu, Yujing Yuan, Li Zhang, Fang Guo, Jian Liu, Zhanzhan Yang, Gang Liu

Journal of Ethnopharmacology · 2025

DOI: 10.1016/j.jep.2025.119321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Yi Xiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, 561113, China. Hauptthemen laut MEDLINE: Phenanthrenes, Platelet Aggregation Inhibitors, Receptors, Purinergic P2Y12, Blood Platelets. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Science and Technology Program of Guizhou Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Cryptotanshinone serves as the principal bioactive constituent of Salvia miltiorrhiza Bunge, possesses a wide range of pharmacological activities. Salvia miltiorrhiza Bunge, a long-standing therapeutic agent in traditional Chinese medicine (TCM) practice, is renowned for its efficacy in enhancing blood circulation and alleviating blood stasis and infarction, thereby treating cardiovascular and cerebrovascular diseases. AIM OF THE STUDY: Platelet activation, when excessive or aberrant, poses a significant risk, catalyzing the onset of various thrombotic disorders. Thus, this investigation is meticulously designed to assess the antiplatelet pharmacological activity of cryptotanshinone, delving into its mechanisms of action that operate independently of the P2Y12 receptor. MATERIALS AND METHODS: We employed a combination of isolated human platelet functional analysis, network pharmacology, molecular docking, and animal experiments to explore the P2Y12 receptor-independent antiplatelet targets and the biological mechanisms by which cryptotanshinone improves thrombosis. RESULTS: Utilizing the ADP-hydrolyzing enzyme apyrase, we isolated the direct effects of cryptotanshinone on platelet function. The findings reveal that cryptotanshinone can effectively inhibit platelet activation in a manner that is independent of the P2Y12 receptor, all the while maintaining normal tail bleeding times in murine models and not exacerbating mesenteric thrombosis. These effects appear to be mediated through intricate signaling pathways, including PI3K-AKT, MAPK, and STAT3. CONCLUSION: This study compellingly confirms the capacity of cryptotanshinone to suppress platelet function independently of the P2Y12 receptor, establishing a robust theoretical foundation for innovative strategies in thrombosis prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenanthrenesPlatelet Aggregation InhibitorsReceptors, Purinergic P2Y12Blood PlateletsAnimalsHumansSignal TransductionMolecular Docking SimulationNetwork PharmacologyThrombosisMaleMicePlatelet AggregationSTAT3 Transcription Factor

Stichwörter der Autor:innen

CryptotanshinoneNetwork pharmacologyPI3K/AKT signalingPlateletThrombosis

Substanzen

cryptotanshinonePhenanthrenesPlatelet Aggregation InhibitorsReceptors, Purinergic P2Y12P2RY12 protein, humanSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Department of Pharmacology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, 561113, China.
  • School of Pharmacy, Guizhou Medical University, Guiyang, 561113, China.
  • School of Laboratory Animal and Shandong Laboratory Animal Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China. Electronic address: ljian@sdfmu.edu.cn.
  • School of Pharmacy, Guizhou Medical University, Guiyang, 561113, China. Electronic address: yangzhanzhan@gmc.edu.cn.
  • Department of Pharmacology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, 561113, China; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Guizhou M…

Förderung

  • Science and Technology Program of Guizhou Province
  • National Natural Science Foundation of China

Zitieren

APA

Xiao, Y., Zhang, R., Hua, C., Wu, M., Yuan, Y., Zhang, L., Guo, F., Liu, J., Yang, Z., & Liu, G. (2025). P2Y12 receptor-independent antiplatelet mechanism of cryptotanshinone: Network pharmacology and experimental validation of multi-target signaling pathways. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.119321

Vancouver

Xiao Y, Zhang R, Hua C, Wu M, Yuan Y, Zhang L, et al. P2Y12 receptor-independent antiplatelet mechanism of cryptotanshinone: Network pharmacology and experimental validation of multi-target signaling pathways. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2025.119321

BibTeX
@article{Xiao2025,
  author = {Xiao, Yi and Zhang, Rui and Hua, Chaoying and Wu, Meng and Yuan, Yujing and Zhang, Li and Guo, Fang and Liu, Jian and Yang, Zhanzhan and Liu, Gang},
  title = {P2Y12 receptor-independent antiplatelet mechanism of cryptotanshinone: Network pharmacology and experimental validation of multi-target signaling pathways},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  doi = {10.1016/j.jep.2025.119321}
}
Kostenlos starten →